These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 17446816)
1. Prevention of coronary heart disease with statins in UK South Asians and Caucasians. Aarabi M; Jackson PR Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):333-9. PubMed ID: 17446816 [TBL] [Abstract][Full Text] [Related]
2. Lipid-lowering for prevention of coronary heart disease: what policy now? Ul Haq I; Ramsay LE; Pickin DM; Yeo WW; Jackson PR; Payne JN Clin Sci (Lond); 1996 Oct; 91(4):399-413. PubMed ID: 8983865 [TBL] [Abstract][Full Text] [Related]
3. Mortality in South Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database. Jones DA; Gallagher S; Rathod KS; Redwood S; de Belder MA; Mathur A; Timmis AD; Ludman PF; Townend JN; Wragg A; JACC Cardiovasc Interv; 2014 Apr; 7(4):362-71. PubMed ID: 24742942 [TBL] [Abstract][Full Text] [Related]
4. A systematic review and economic evaluation of statins for the prevention of coronary events. Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535 [TBL] [Abstract][Full Text] [Related]
5. Ethnicity and risk factors for coronary heart disease in diabetes mellitus. Game FL; Jones AF Diabetes Obes Metab; 2000 Apr; 2(2):91-7. PubMed ID: 11220529 [TBL] [Abstract][Full Text] [Related]
6. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Pletcher MJ; Lazar L; Bibbins-Domingo K; Moran A; Rodondi N; Coxson P; Lightwood J; Williams L; Goldman L Ann Intern Med; 2009 Feb; 150(4):243-54. PubMed ID: 19221376 [TBL] [Abstract][Full Text] [Related]
7. The causes and effects of socio-demographic exclusions from clinical trials. Bartlett C; Doyal L; Ebrahim S; Davey P; Bachmann M; Egger M; Dieppe P Health Technol Assess; 2005 Oct; 9(38):iii-iv, ix-x, 1-152. PubMed ID: 16181564 [TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Tillin T; Forouhi N; Johnston DG; McKeigue PM; Chaturvedi N; Godsland IF Diabetologia; 2005 Apr; 48(4):649-56. PubMed ID: 15759110 [TBL] [Abstract][Full Text] [Related]
9. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. Bhopal R; Fischbacher C; Vartiainen E; Unwin N; White M; Alberti G J Public Health (Oxf); 2005 Mar; 27(1):93-100. PubMed ID: 15749725 [TBL] [Abstract][Full Text] [Related]
10. Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey. Haq IU; Ramsay LE; Wallis EJ; Isles CG; Ritchie LD; Jackson PR Heart; 2001 Sep; 86(3):289-95. PubMed ID: 11514481 [TBL] [Abstract][Full Text] [Related]
11. Ethnic variation in C-reactive protein: UK resident Indo-Asians compared with Caucasians. Chatha K; Anderson NR; Gama R J Cardiovasc Risk; 2002 Jun; 9(3):139-41. PubMed ID: 12202835 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of prescribing statins according to pharmaceutical benefits scheme criteria. Lim SS; Vos T; Peeters A; Liew D; McNeil JJ Med J Aust; 2001 Nov; 175(9):459-64. PubMed ID: 11758073 [TBL] [Abstract][Full Text] [Related]
13. Coronary risk in South Asians: role of ethnicity and blood sugar. Aarabi M; Jackson PR Eur J Cardiovasc Prev Rehabil; 2004 Oct; 11(5):389-93. PubMed ID: 15616411 [TBL] [Abstract][Full Text] [Related]
14. South Asians and coronary disease: is there discordance between effects on incidence and prognosis? Zaman MJ; Philipson P; Chen R; Farag A; Shipley M; Marmot MG; Timmis AD; Hemingway H Heart; 2013 May; 99(10):729-36. PubMed ID: 23406688 [TBL] [Abstract][Full Text] [Related]
15. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study. Tillin T; Hughes AD; Mayet J; Whincup P; Sattar N; Forouhi NG; McKeigue PM; Chaturvedi N J Am Coll Cardiol; 2013 Apr; 61(17):1777-86. PubMed ID: 23500273 [TBL] [Abstract][Full Text] [Related]
16. Ethnic differences in total and HDL cholesterol concentrations: Caucasians compared with predominantly Punjabi Sikh Indo-Asians. Gama R; Elfatih AB; Anderson NR Ann Clin Biochem; 2002 Nov; 39(Pt 6):609-11. PubMed ID: 12564846 [TBL] [Abstract][Full Text] [Related]
17. Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010. Fidan D; Unal B; Critchley J; Capewell S QJM; 2007 May; 100(5):277-89. PubMed ID: 17449875 [TBL] [Abstract][Full Text] [Related]
18. Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease - A population-wide electronic cohort study. King W; Lacey A; White J; Farewell D; Dunstan F; Fone D PLoS One; 2018; 13(3):e0194081. PubMed ID: 29522561 [TBL] [Abstract][Full Text] [Related]
19. Statin therapy in the elderly: does it make good clinical and economic sense? Mungall MM; Gaw A; Shepherd J Drugs Aging; 2003; 20(4):263-75. PubMed ID: 12641482 [TBL] [Abstract][Full Text] [Related]
20. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Misra A; Khurana L Int J Obes (Lond); 2011 Feb; 35(2):167-87. PubMed ID: 20644557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]